Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure

Copyright: © Vasuri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. We evaluated the long...

Full description

Bibliographic Details
Main Authors: Vasuri, Francesco, Degiovanni, Alessio, Gargiulo, Mauro, Thilly, William G, Gostjeva, Elena V., Pasquinelli, Gianandrea, Fittipaldi, Silvia
Other Authors: Massachusetts Institute of Technology. Laboratory in Metakaryotic Biology
Format: Article
Language:English
Published: Impact Journals, LLC 2021
Online Access:https://hdl.handle.net/1721.1/133598.2
_version_ 1811079124066762752
author Vasuri, Francesco
Degiovanni, Alessio
Gargiulo, Mauro
Thilly, William G
Gostjeva, Elena V.
Pasquinelli, Gianandrea
Fittipaldi, Silvia
author2 Massachusetts Institute of Technology. Laboratory in Metakaryotic Biology
author_facet Massachusetts Institute of Technology. Laboratory in Metakaryotic Biology
Vasuri, Francesco
Degiovanni, Alessio
Gargiulo, Mauro
Thilly, William G
Gostjeva, Elena V.
Pasquinelli, Gianandrea
Fittipaldi, Silvia
author_sort Vasuri, Francesco
collection MIT
description Copyright: © Vasuri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. We evaluated the long-term effects of sirolimus on three different cell in vitro models, cultured in physiological conditions mimicking sirolimus-eluted stent, in order to clarify the effectiveness of sirolimus in blocking cell proliferation and survival. Three cells lines (WPMY-1 myofibroblasts, HT-29 colorectal adenocarcinoma, and U2OS osteosarcoma) were selected and growth in 10 ml of Minimum Essential Medium for 5 weeks with serial dilutions of sirolimus. The number of colonies and the number of cells per colony were counted. As main result, the number of WPMY-1 surviving colonies increased in a dose-dependent manner when treated with sirolimus (p = 0.0011), while the number of U2OS colonies progressively decreased (p = 0.0011). The clonal capacity of HT-29 was not modified by the exposure to sirolimus (p = 0.6679). In conclusion sirolimus showed the well-known cytostatic effect, but with an effect on clonogenic potential different among the different cell types. In the practice, the plaque typology and composition may influence the response to sirolimus and thus the effectiveness of eluted stent.
first_indexed 2024-09-23T11:10:25Z
format Article
id mit-1721.1/133598.2
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T11:10:25Z
publishDate 2021
publisher Impact Journals, LLC
record_format dspace
spelling mit-1721.1/133598.22021-12-06T14:11:09Z Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure Vasuri, Francesco Degiovanni, Alessio Gargiulo, Mauro Thilly, William G Gostjeva, Elena V. Pasquinelli, Gianandrea Fittipaldi, Silvia Massachusetts Institute of Technology. Laboratory in Metakaryotic Biology Massachusetts Institute of Technology. Department of Biological Engineering Copyright: © Vasuri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. We evaluated the long-term effects of sirolimus on three different cell in vitro models, cultured in physiological conditions mimicking sirolimus-eluted stent, in order to clarify the effectiveness of sirolimus in blocking cell proliferation and survival. Three cells lines (WPMY-1 myofibroblasts, HT-29 colorectal adenocarcinoma, and U2OS osteosarcoma) were selected and growth in 10 ml of Minimum Essential Medium for 5 weeks with serial dilutions of sirolimus. The number of colonies and the number of cells per colony were counted. As main result, the number of WPMY-1 surviving colonies increased in a dose-dependent manner when treated with sirolimus (p = 0.0011), while the number of U2OS colonies progressively decreased (p = 0.0011). The clonal capacity of HT-29 was not modified by the exposure to sirolimus (p = 0.6679). In conclusion sirolimus showed the well-known cytostatic effect, but with an effect on clonogenic potential different among the different cell types. In the practice, the plaque typology and composition may influence the response to sirolimus and thus the effectiveness of eluted stent. 2021-12-06T14:11:08Z 2021-10-27T19:53:44Z 2021-12-06T14:11:08Z 2020 2021-09-10T15:04:10Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/133598.2 en 10.18632/ONCOTARGET.27554 Oncotarget Creative Commons Attribution 3.0 unported license https://creativecommons.org/licenses/by/3.0/ application/octet-stream Impact Journals, LLC Oncotarget
spellingShingle Vasuri, Francesco
Degiovanni, Alessio
Gargiulo, Mauro
Thilly, William G
Gostjeva, Elena V.
Pasquinelli, Gianandrea
Fittipaldi, Silvia
Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title_full Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title_fullStr Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title_full_unstemmed Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title_short Sirolimus-eluting stents: opposite in vitro effects on the clonogenic cell potential on a long-term exposure
title_sort sirolimus eluting stents opposite in vitro effects on the clonogenic cell potential on a long term exposure
url https://hdl.handle.net/1721.1/133598.2
work_keys_str_mv AT vasurifrancesco sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT degiovannialessio sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT gargiulomauro sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT thillywilliamg sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT gostjevaelenav sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT pasquinelligianandrea sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure
AT fittipaldisilvia sirolimuselutingstentsoppositeinvitroeffectsontheclonogeniccellpotentialonalongtermexposure